Our vaccines portfolio


Boostrix
Diphtheria, tetanus and pertussis
(acellular, component) vaccine
(adsorbed, reduced antigen(s) content)

IPV‐Boostrix
Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

Cervarix
Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed)

Engerix B 20mcg (Adult)
Hepatitis B (rDNA) vaccine (adsorbed) (HBV)

Engerix B 10mcg (Paediatric)
Hepatitis B (rDNA) vaccine (adsorbed) (HBV)

Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)

Hepatitis A Vaccine
(inactivated, adsorbed)

Hepatitis A Vaccine
(inactivated, adsorbed)

Hiberix
Haemophilus Type b (Hib) vaccine

Infanrix Hexa
Diphtheria (D), tetanus (T),
pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)

Menitorix
Haemophilus type b and Meningococcal group C conjugate vaccine

Menjugate
Meningococcal group C conjugate vaccine

Menveo
Meningococcal Group A, C, W135 and Y conjugate vaccine

Measles, Mumps and Rubella vaccine (live)

rotavirus vaccine, live

Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)

Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Bexsero, Boostrix, IPV-Boostrix, Cervarix, Engerix B, Fendrix, Havrix, Hiberix, Infanrix Hexa, Menitorix, Menjugate, Menveo, Priorix, Rotarix and Twinrix are registered trademarks of the GlaxoSmithKline Group of Companies.